Gateways to clinical trials . Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses . The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity , the drug discovery and development portal , http://integrity.prous.com . This issue focuses on the following selection of drugs : 2F5 , 2G12 , abetimus sodium , ABI-007 , adalimumab , adefovir dipivoxil , DB05387 , alefacept , altropane , aminolevulinic acid hydrochloride , aminolevulinic acid methyl ester , aminopterin , anakinra , aprinocarsen sodium , atazanavir , atlizumab , atomoxetine hydrochloride ; P33681 -1 vaccine , bevacizumab , DB04851 dicitrate , BMS-188667 , brasofensine sulfate , bryostatin 1 ; cantuzumab mertansine , Q99698 -828 , cinacalcet hydrochloride , cipamfylline , creatine , CVT-3146 ; darbepoetin alfa , DITPA , drotrecogin alfa ( activated ) , duloxetine hydrochloride ; edatrexate , efalizumab , ENMD-0997 , epoetin , erlosamide , esomeprazole magnesium , etiprednol dicloacetate , etoricoxib , everolimus , ezetimibe ; fampridine , fenretinide , FTY-720 ; P05019 / P17936 , IL-1 cytokine trap , ilodecakin , interferon beta , ISIS-104838 , ISIS-2503 , ISIS-5132 , ivabradine hydrochloride ; lafutidine , lanthanum carbonate , l- DB00125 hydrochloride , DB06681 , lerdelimumab , levetiracetam , levobupivacaine hydrochloride , levosimendan , lopinavir ; melagatran , mibefradil hydrochloride , miglustat , morphine-6-glucuronide ; nesiritide ; omalizumab , omapatrilat ; p24-VLP , parecoxib sodium , peginterferon alfa-2a , peginterferon alfa-2b , pegsunercept , pitavastatin calcium , plevitrexed , prasterone , pregabalin , PRO-2000 , prucalopride ; rapacuronium bromide , rebimastat , RGA-0853 , rubitecan , ruboxistaurin mesilate hydrate , RWJ-67657 ; S-16020-2 , sarizotan , SLV-306 , stiripentol ; DB05809 , tenecteplase , teriparatide , tezacitabine , tipifarnib , trabectedin , troglitazone ; valdecoxib , vardenafil ; Z-338 , ziconotide .